These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15179015)

  • 21. [Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder].
    Numajiri M; Aoki J; Iwahashi K; Fukamauchi F; Enomoto M; Yoshihara E; Murayama O; Nishizawa D; Ikeda K; Ishigooka J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Jun; 32(3):161-3. PubMed ID: 22834106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of glycogen synthase kinase-3beta in schizophrenia.
    Koros E; Dorner-Ciossek C
    Drug News Perspect; 2007 Sep; 20(7):437-45. PubMed ID: 17992266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response.
    Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; Wong AH; Kennedy JL
    Psychopharmacology (Berl); 2008 Oct; 200(2):177-86. PubMed ID: 18500637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutively active glycogen synthase kinase-3beta gene transfer sustains apoptosis, inhibits proliferation of vascular smooth muscle cells, and reduces neointima formation after balloon injury in rats.
    Park KW; Yang HM; Youn SW; Yang HJ; Chae IH; Oh BH; Lee MM; Park YB; Choi YS; Kim HS; Walsh K
    Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1364-9. PubMed ID: 12805073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between gene polymorphisms of Wnt signalling pathway related components and risk of gastric carcinoma: a case-control study].
    Zheng HP; Zhou W; Xu LH; Si JM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):647-51. PubMed ID: 17160944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GSK-3beta in cerebrospinal fluid of schizophrenia patients.
    Kozlovsky N; Regenold WT; Levine J; Rapoport A; Belmaker RH; Agam G
    J Neural Transm (Vienna); 2004 Aug; 111(8):1093-8. PubMed ID: 15254796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey.
    Ozbey U; Tug E; Namli M
    World J Biol Psychiatry; 2009; 10(4 Pt 2):461-8. PubMed ID: 19153889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients.
    Kozlovsky N; Belmaker RH; Agam G
    Am J Psychiatry; 2000 May; 157(5):831-3. PubMed ID: 10784483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Association Study Between Genetic Polymorphisms in Functional Regions of Five Genes and the Risk of Schizophrenia.
    Yan P; Qiao X; Wu H; Yin F; Zhang J; Ji Y; Wei S; Lai J
    J Mol Neurosci; 2016 Jul; 59(3):366-75. PubMed ID: 27055860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia.
    Kaiser R; Tremblay PB; Schmider J; Henneken M; Dettling M; Müller-Oerlinghausen B; Uebelhack R; Roots I; Brockmöller J
    Mol Psychiatry; 2001 Mar; 6(2):179-85. PubMed ID: 11317220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.
    Tang H; Shen N; Jin H; Liu D; Miao X; Zhu LQ
    Mol Neurobiol; 2013 Dec; 48(3):404-11. PubMed ID: 23440732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.
    Amar S; Shaltiel G; Mann L; Shamir A; Dean B; Scarr E; Bersudsky Y; Belmaker RH; Agam G
    Int J Neuropsychopharmacol; 2008 Mar; 11(2):197-205. PubMed ID: 17681085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophrenia.
    Bowen T; Guy CA; Craddock N; Cardno AG; Williams NM; Spurlock G; Murphy KC; Jones LA; Gray M; Sanders RD; McCarthy G; Chandy KG; Fantino E; Kalman K; Gutman GA; Gargus JJ; Williams J; McGuffin P; Owen MJ; O'Donovan MC
    Mol Psychiatry; 1998 May; 3(3):266-9. PubMed ID: 9672903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia.
    Ide M; Ohnishi T; Murayama M; Matsumoto I; Yamada K; Iwayama Y; Dedova I; Toyota T; Asada T; Takashima A; Yoshikawa T
    J Neurochem; 2006 Oct; 99(1):277-87. PubMed ID: 16987250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women.
    Sazci A; Ergul E; Kucukali I; Kara I; Kaya G
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1113-23. PubMed ID: 16084002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
    Cui J; Zhou X; Liu Y; Tang Z; Romeih M
    Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between GSK-3 beta -50T/C and DBI +529A/T polymorphisms in Japanese alcoholics].
    Kurihara K; Aoki J; Numajiri M; Ikeda K; Kawai A; Waga C; Yoshihara E; Murayama O; Iwahashi K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Oct; 45(5):430-6. PubMed ID: 21226341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant association of close homologue of L1 gene polymorphism rs2272522 with schizophrenia in Qatar.
    Shaltout TE; Alali KA; Bushra S; Alkaseri AM; Jose ED; Al-Khainji M; Saleh R; Salama Dahir A; Shaltout H; Al-Abdullah M; Rizk NM
    Asia Pac Psychiatry; 2013 Mar; 5(1):17-23. PubMed ID: 23857787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia.
    Tsai SJ; Wang YC; Hong CJ
    Psychiatr Genet; 2000 Sep; 10(3):149-51. PubMed ID: 11204352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.